Avista Healthcare
IRVING, Texas, January 8, 2018 — Miraca Life Sciences announced today that it has changed its name to Inform Diagnostics effective immediately. The company was acquired in November by Avista Capital Partners from previous owner Miraca Holdings. The name Inform Diagnostics and new logo were chosen to highlight the company’s focus on providing pathology and diagnostic […]
St. Louis and New York, November 27, 2017 – Express Scripts (NASDAQ: ESRX) and Avista Capital Partners, a leading private equity firm, announced today that Avista has signed a definitive agreement to acquire United BioSource (UBC), a wholly-owned subsidiary of Express Scripts Holding Company. Founded in 2003 and headquartered in Blue Bell, Pennsylvania, UBC is […]
IRVING, Texas and NEW YORK, Nov. 20, 2017 – /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm, today announced the completion of its acquisition of Miraca Life Sciences (“MLS” or the “Company”) from Miraca Holdings Inc. MLS is one of the largest independent anatomic pathology labs in the United States. The Company […]
Yardley, PA, Oct. 17, 2017 – OptiNose, Inc. (NASDAQ:OPTN), a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the closing of its initial public offering of 8,625,000 shares of common stock at a public offering price of $16.00 […]
IRVING, TX, NEW YORK, NY, and TOKYO, September 22, 2017 – Avista Capital Partners (“Avista”), a leading private equity firm, and Miraca Holdings Inc. (“MHD”) announced today that Avista has signed a definitive agreement to acquire Miraca Life Sciences (“MLS” or “the Company”), a wholly-owned subsidiary of Miraca Holdings Inc. Since its acquisition by MHD […]
XHANCE uses Optinose® Exhalation Delivery System to uniquely deposit a proven steroid in areas of inflammation deep in the nose FDA approval based on five clinical trials evaluating over 1,500 adult patients Availability in the U.S. expected in the second quarter 2018 Yardley, PA, Sept. 18, 2017 – (Business Wire) – Optinose, an ENT / […]
Stockholm, June 28th 2017 – (Business Wire) – Trimb Healthcare AB (“Trimb”) has acquired a portfolio of well-established European OTC products from Cilag GmbH International and Janssen Pharmaceutica NV (collectively, “J&J”). The products, which include Pevaryl®, Fungoral®, Gyno-Pevaryl® and Epi-Pevaryl®, are based on the anti-fungal substances econazole and ketoconazole and are used to treat common […]
North Billerica, MA, June 14 2017 – (Business Wire) – Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ:LNTH), today announced an agreement to sell 3,000,000 shares of its common stock to be offered by certain of its existing stockholders (the “Selling Stockholders”), pursuant to an effective shelf registration statement filed with the Securities and Exchange […]
Private equity groups Nordic Capital and Avista Capital Partners raised gross proceeds of 805 million pounds through the sale of British medical technology giant ConvaTec Group Plc (CTEC.L). The investors sold an aggregate of 250 million shares at 322 pence per share, after the size of the placing was increased due to strong investor demand. […]
Rockville, MD and New York, June 5, 2017 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm, and National Spine & Pain Centers, LLC (“NSPC” or “the Company”) announced that Avista has acquired NSPC from Sentinel Capital Partners (“Sentinel”). Founded in 1998 and headquartered in Rockville, Maryland, NSPC is a leading management services […]
Yardley, PA, May 9, 2017 – (Business Wire) – OptiNose, a commercial-stage ENT / Allergy specialty pharmaceutical company, today announced that it has closed a $37 million Series D financing led by Fidelity Management and Research Company with participation from Avista Capital Partners, Entrepreneurs Fund and other current investors. OptiNose will use the additional capital […]
Avantor to Acquire VWR for $33.25 per Common Share In An All Cash Transaction Valued At $6.4 Billion Avantor’s Acquisition of VWR Will Create a Vertically Integrated, Global Player in Manufacturing and Supply Chain Solutions for the Life Sciences, Advanced Technologies, and Research Industries Combined Company Will Provide Broad Offerings and Compelling Solutions for Customers […]